Rose Geoffrey Beran

Officer · LUNG

As of 2026-09-16, Rose Geoffrey Beran has 31 Form 4 transactions on record across 1 company — 17 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Pattern in the record: open-market sales filed in September in multiple years since 2025 — a recurring calendar cadence, more consistent with scheduled activity than a one-off decision.

Reconstructed holdings

Direct: $877KIndirect: $0$877Kas of 2026-09-16
  • Direct $877K
  • Indirect $0
LUNGdirect449,832 sh$877K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

LUNG · 31 trades
2026-09-01: Sale, 2,390 sh ($5K)2026-09-01: Sale, 2,213 sh ($5K)2026-09-01: Sale, 1,746 sh ($4K)2026-09-01: Sale, 1,530 sh ($3K)2026-06-01: Sale, 2,434 sh ($4K)2026-06-01: Sale, 2,254 sh ($3K)2026-06-01: Sale, 1,778 sh ($3K)2026-06-01: Sale, 1,557 sh ($2K)2026-03-02: Sale, 2,911 sh ($4K)2026-03-02: Sale, 2,125 sh ($3K)2026-03-02: Sale, 1,861 sh ($3K)2026-03-02: Sale, 835 sh ($1K)2026-03-02: Award / grant, 100,000 sh ($0)2025-12-01: Sale, 2,379 sh ($4K)2025-12-01: Sale, 1,738 sh ($3K)2025-12-01: Sale, 1,522 sh ($2K)2025-12-01: Sale, 683 sh ($1K)2025-09-02: Sale, 2,462 sh ($4K)2025-09-02: Sale, 1,799 sh ($3K)2025-09-02: Sale, 1,575 sh ($3K)2025-09-02: Sale, 707 sh ($1K)2025-06-02: Sale, 2,463 sh ($8K)2025-06-02: Sale, 1,799 sh ($6K)2025-06-02: Sale, 1,576 sh ($5K)2025-06-02: Sale, 708 sh ($2K)2025-06-02: Sale, 401 sh ($1K)2025-03-03: Sale, 2,327 sh ($17K)2025-03-03: Sale, 2,017 sh ($14K)2025-03-03: Sale, 915 sh ($7K)2025-03-03: Sale, 520 sh ($4K)2025-03-03: Award / grant, 108,000 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-09-01LUNGSale2,390 @ $2.26$5K−0.5% of holding453,108Form 4
2026-09-01LUNGSale2,213 @ $2.26$5K−0.5% of holding455,498Form 4
2026-09-01LUNGSale1,746 @ $2.26$4K−0.4% of holding449,832Form 4
2026-09-01LUNGSale1,530 @ $2.26$3K−0.3% of holding451,578Form 4
2026-06-01LUNGSale2,434 @ $1.54$4K−0.5% of holding459,965Form 4
2026-06-01LUNGSale2,254 @ $1.54$3K−0.5% of holding457,711Form 4
2026-06-01LUNGSale1,778 @ $1.54$3K−0.4% of holding463,956Form 4
2026-06-01LUNGSale1,557 @ $1.54$2K−0.3% of holding462,399Form 4
2026-03-02LUNGSale2,911 @ $1.43$4K−0.8% of holding365,734Form 4
2026-03-02LUNGSale2,125 @ $1.43$3K−0.6% of holding370,506Form 4
2026-03-02LUNGSale1,861 @ $1.43$3K−0.5% of holding368,645Form 4
2026-03-02LUNGSale835 @ $1.43$1K−0.2% of holding372,631Form 4
2025-12-01LUNGSale2,379 @ $1.57$4K−0.6% of holding373,466Form 4
2025-12-01LUNGSale1,738 @ $1.57$3K−0.5% of holding377,367Form 4
2025-12-01LUNGSale1,522 @ $1.57$2K−0.4% of holding375,845Form 4
2025-12-01LUNGSale683 @ $1.57$1K−0.2% of holding379,105Form 4
2025-09-02LUNGSale2,462 @ $1.60$4K−0.6% of holding379,788Form 4
2025-09-02LUNGSale1,799 @ $1.60$3K−0.5% of holding383,825Form 4
2025-09-02LUNGSale1,575 @ $1.60$3K−0.4% of holding382,250Form 4
2025-09-02LUNGSale707 @ $1.60$1K−0.2% of holding385,624Form 4
2025-06-02LUNGSale2,463 @ $3.13$8K−0.6% of holding386,331Form 4
2025-06-02LUNGSale1,799 @ $3.13$6K−0.5% of holding390,370Form 4
2025-06-02LUNGSale1,576 @ $3.13$5K−0.4% of holding388,794Form 4
2025-06-02LUNGSale708 @ $3.13$2K−0.2% of holding392,169Form 4
2025-06-02LUNGSale401 @ $3.14$1K−0.1% of holding392,877Form 4
2025-03-03LUNGSale2,327 @ $7.14$17K−0.8% of holding287,295Form 4
2025-03-03LUNGSale2,017 @ $7.12$14K−0.7% of holding285,278Form 4
2025-03-03LUNGSale915 @ $7.12$7K−0.3% of holding289,622Form 4
2025-03-03LUNGSale520 @ $7.12$4K−0.2% of holding290,537Form 4
2 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-03-02LUNGAward / grant100,000465,734Form 4
2025-03-03LUNGAward / grant108,000393,278Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.